Malin Corporation reported EUR0 in Loan Capital for its fiscal semester ending in December of 2024.





Loan Capital Change Date
Akebia Therapeutics USD 12.78M 11.98M Sep/2026
Alaunos Therapeutics USD 4.47M 5.85M Jun/2022
ALKERMES USD 1.47B 5.38M Sep/2026
Avita Medical AUD 42.24M 1.25M Dec/2024
Dianthus Therapeutics USD 0 0 Dec/2024
Eurofins Scientific SE EUR 3.7B 5M Jun/2026
Ionis Pharmaceuticals USD 1.77B 140.62M Sep/2026
IQVIA Holdings USD 14.82B 1.12B Sep/2026
Lonza CHF 3.88B 323M Dec/2025
Malin Corporation EUR 0 0 Dec/2024
Moderna USD 3.55B 2.95B Sep/2026
Organon & Co USD 8.49B 6M Sep/2026
Ovoca Bio EUR 0 0 Jun/2021
Revvity USD 2.63B 968K Sep/2026
Tectonic Therapeutic USD 17K 26K Mar/2026
Viatris USD 11.59B 24.9M Sep/2026
Xeris Pharmaceuticals USD 189.71M 906K Sep/2026